Cancer Research Institute (CRI) shared OncoDaily’s latest original article about Immunotherapy on X:
“Who benefits most from immunotherapy, and why doesn’t it work for everyone?
Understand what shapes immunotherapy’s efficacy, and review the potential benefits, side effects, and risks of this treatment, with OncoDaily.”
Read “Immunotherapy for Cancer Success Rate: What Patients Need to Know in 2025“.
